← Open Payments lookup

ERICA GRIFFIN: Open Payments

NPI 1558721894 · TEMPLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,124 in 89 payments from 10 companies in 2025. Trend: 2023 $909 · 2024 $790 · 2025 $1,124

Food & beverage: $1,124
CompanyPaymentsAmount
ABBVIE INC.34$250
Neurocrine BioSciences, Inc.9$167
Otsuka America Pharmaceutical, Inc.12$161
Teva Pharmaceuticals USA, Inc.10$153
Vanda Pharmaceuticals Inc.11$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$69
Axsome Therapeutics, Inc.3$67
Takeda Pharmaceuticals U.S.A., Inc.3$52
Alkermes, Inc.2$40
E.R. Squibb & Sons, L.L.C.1$17

Products named: VRAYLAR, INGREZZA, FANAPT, AUSTEDO XR, REXULTI, CAPLYTA, Auvelity, TRINTELLIX.

Industry payments across GA — which companies pay providers there.